Back to Journals » Clinical Interventions in Aging » Volume 12

Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Total article views   HTML views PDF downloads Totals
22,769 Dovepress* 16,145+ 3,191 19,336
PubMed Central* 6,624 1,559 8,183
Totals 22,769 4,750 27,519
*Since 18 April 2017
Total mentioned Facebook Delicious Reddit Twitter Others
30 0 0 0 14 16

View citations on PubMed Central and Google Scholar